These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nipple aspirate fluid color is associated with breast cancer. Sauter ER; Winn JN; Dale PS; Wagner-Mann C Cancer Detect Prev; 2006; 30(4):322-8. PubMed ID: 16963197 [TBL] [Abstract][Full Text] [Related]
3. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions? Masood S; Loya A; Khalbuss W Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640 [TBL] [Abstract][Full Text] [Related]
4. Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens. Sharma P; Klemp JR; Simonsen M; Welsko CM; Zalles CM; Kimler BF; Fabian CJ Breast Cancer Res Treat; 2004 Sep; 87(1):59-64. PubMed ID: 15377851 [TBL] [Abstract][Full Text] [Related]
5. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions. Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687 [TBL] [Abstract][Full Text] [Related]
6. Fiberoptic ductoscopy for breast cancer patients with nipple discharge. Shen KW; Wu J; Lu JS; Han QX; Shen ZZ; Nguyen M; Barsky SH; Shao ZM Surg Endosc; 2001 Nov; 15(11):1340-5. PubMed ID: 11727147 [TBL] [Abstract][Full Text] [Related]
7. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Sauter ER; Ehya H; Babb J; Diamandis E; Daly M; Klein-Szanto A; Sigurdson E; Hoffman J; Malick J; Engstrom PF Br J Cancer; 1999 Dec; 81(7):1222-7. PubMed ID: 10584885 [TBL] [Abstract][Full Text] [Related]
8. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up. Ringberg A; Andersson I; Aspegren K; Linell F Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650 [TBL] [Abstract][Full Text] [Related]
9. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge. Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063 [TBL] [Abstract][Full Text] [Related]
10. Ductal lavage findings in women with known breast cancer undergoing mastectomy. Khan SA; Wiley EL; Rodriguez N; Baird C; Ramakrishnan R; Nayar R; Bryk M; Bethke KB; Staradub VL; Wolfman J; Rademaker A; Ljung BM; Morrow M J Natl Cancer Inst; 2004 Oct; 96(20):1510-7. PubMed ID: 15494601 [TBL] [Abstract][Full Text] [Related]
12. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast. Carder PJ; Garvican J; Haigh I; Liston JC Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418 [TBL] [Abstract][Full Text] [Related]
13. Histopathologic analysis of atypical lesions in image-guided core breast biopsies. Bonnett M; Wallis T; Rossmann M; Pernick NL; Bouwman D; Carolin KA; Visscher D Mod Pathol; 2003 Feb; 16(2):154-60. PubMed ID: 12591968 [TBL] [Abstract][Full Text] [Related]
14. Nipple aspirate cytology and pathologic parameters predict residual cancer and nodal involvement after excisional breast biopsy. Sauter ER; Ehya H; Mammen A; Klein G Br J Cancer; 2001 Dec; 85(12):1952-7. PubMed ID: 11747339 [TBL] [Abstract][Full Text] [Related]
15. Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study. Krishnamurthy S; Zhao L; Hayes K; Glassman AB; Cristofanilli M; Singletary SE; Hunt KK; Kuerer HM; Sneige N Cancer; 2004 Oct; 102(5):322-7. PubMed ID: 15376199 [TBL] [Abstract][Full Text] [Related]
16. Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens. Brachtel EF; Rusby JE; Michaelson JS; Chen LL; Muzikansky A; Smith BL; Koerner FC J Clin Oncol; 2009 Oct; 27(30):4948-54. PubMed ID: 19720921 [TBL] [Abstract][Full Text] [Related]
17. Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge. Liu GY; Lu JS; Shen KW; Wu J; Chen CM; Hu Z; Shen ZZ; Zhang TQ; Shao ZM Breast Cancer Res Treat; 2008 Mar; 108(2):271-7. PubMed ID: 17473979 [TBL] [Abstract][Full Text] [Related]
18. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ. Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343 [TBL] [Abstract][Full Text] [Related]
19. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins. Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190 [TBL] [Abstract][Full Text] [Related]
20. Correlation of nipple aspiration and ductal lavage cytology with histopathologic findings for patients before scheduled breast biopsy examination. West KE; Wojcik EM; Dougherty TA; Siziopikou KP; Albain KS; Gabram SG Am J Surg; 2006 Jan; 191(1):57-60. PubMed ID: 16399107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]